TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer
Open Access
- 29 August 2024
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-13
Abstract
Liver cancer stem cells (LCSCs) are responsible for recurrence, metastasis, and drug resistance in liver cancer. However, the genes responsible for inducing LCSCs have not been fully identified. Based on our previous study, we found that tescalcin (TESC), a calcium-binding EF hand protein that plays a crucial role in chromatin remodeling, transcriptional regulation, and epigenetic modifications, was up-regulated in LCSCs of spheroid cultures. By searching the Cancer Genome Atlas, International Cancer Genome Consortium, Human Protein Atlas, and Kaplan–Meier Plotter databases, we found that TESC expression was significantly elevated in liver cancer compared with that in normal liver tissue and was predictive of a decreased overall survival rate. Multivariate Cox analysis revealed TESC to be an independent prognostic factor for survival. High TESC expression was positively associated with cancer stem cell pathways, cancer stem cell surface markers, stemness transcription factors, epithelial–mesenchymal transition (EMT) factors, immune checkpoint proteins, and various cancer-related biological processes in liver cancer. Furthermore, TESC was implicated as promoting cancer stem cell properties through its influence on EMT. We demonstrated that TESC is a novel stemness-related gene that can serve as an independent prognostic factor for liver cancer.Keywords
Funding Information
- The Science and Technology Project of Guangzhou Health Commission (20241A011117)
- the Science and Technology Project of Panyu District, Guangzhou (2023-Z04-021)
- the Internal Scientific Research Fund of Guangzhou Panyu Central Hospital (PY-2023-025)
- The National Natural Science Foundation of China (82172789)
- Project of Educational Commission of Guangdong Province of China (2021KCXTD023)
- the YingTsai Young Scholar Award (CMU108-YTY-04)
- the National Science and Technology Council, Taiwan (NSTC 112-2320-B-039-024)
This publication has 25 references indexed in Scilit:
- TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinomaPathology - Research and Practice, 2023
- A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancerSeminars in Cancer Biology, 2023
- The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinomaCancer Gene Therapy, 2021
- EMT, cancer stem cells and autophagy; The three main axes of metastasisBiomedicine & Pharmacotherapy, 2021
- Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patientsCancer Communications, 2020
- Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistanceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Milestones in the pathogenesis and management of primary liver cancerJournal of Hepatology, 2020
- Targeting Cancer Stemness in the Clinic: From Hype to HopeCell Stem Cell, 2019
- Tescalcin is a potential target of class I histone deacetylase inhibitors in neuronsBiochemical and Biophysical Research Communications, 2017
- Tescalcin expression contributes to invasive and metastatic activity in colorectal cancerTumor Biology, 2016